✦ LIBER ✦

Phase 2 study of rituximab in newly diagnosed stage IA nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group

✍ Scribed by Eichenauer, D. A.; Fuchs, M.; Pluetschow, A.; Klimm, B.; Halbsguth, T.; Boll, B.; von Tresckow, B.; Nogova, L.; Borchmann, P.; Engert, A.

Book ID: 125512076
Publisher: American Society of Hematology
Year: 2011
Tongue: English
Weight: 96 KB
Volume: 118
Category: Article
ISSN: 0006-4971
DOI: 10.1182/blood-2011-06-361055

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase 2 study of rituximab plus ABVD in

Phase 2 study of rituximab plus ABVD in patients with newly diagnosed classical Hodgkin lymphoma

✍ Younes, A.; Oki, Y.; McLaughlin, P.; Copeland, A. R.; Goy, A.; Pro, B.; Feng, L. 📂 Article 📅 2012 🏛 American Society of Hematology 🌐 English ⚖ 664 KB

Extended field radiotherapy, combined mo

Extended field radiotherapy, combined modality treatment or involved field radiotherapy for patients with stage IA lymphocyte-predominant Hodgkin's lymphoma: a retrospective analysis from the German Hodgkin Study Group (GHSG)

✍ Nogova, L. 📂 Article 📅 2005 🏛 Oxford University Press 🌐 English ⚖ 87 KB

Fatigue in long-term survivors of Hodgki

Fatigue in long-term survivors of Hodgkin‘s lymphoma; a report from the German Hodgkin Lymphoma Study Group (GHSG)

✍ J.U. Rüffer; H. Flechtner; P. Tralls; A. Josting; M. Sieber; B. Lathan; V. Diehl 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 211 KB

Nodular, lymphocyte-predominant Hodgkin

Nodular, lymphocyte-predominant Hodgkin lymphoma : A long-term study and analysis of transformation to diffuse large B-cell lymphoma in a cohort of 164 patients from the Adult Lymphoma Study Group

✍ Irene Biasoli; Aspasia Stamatoullas; Véronique Meignin; Alain Delmer; Oumedaly R 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 213 KB 👁 1 views

The German Hodgkin Study Group Stratific

The German Hodgkin Study Group Stratification Scheme for Newly Diagnosed Hodgkin Lymphoma Is Useful for Predicting Outcome of Patients Receiving Radiation Therapy After Autologous Self Cell Transplant in Relapsed/Refractory Hodgkin Lymphoma

✍ Furlan, C.; Michieli, M.; Bortolus, R.; Mascarin, M.; Avanzo, M.; Rupolo, M.; Za 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 55 KB

IDEC-C2B8 (Rituximab) anti-CD20 antibody

IDEC-C2B8 (Rituximab) anti-CD20 antibody treatment in relapsed advanced-stage follicular lymphomas: results of a phase-II study of the German Low-Grade Lymphoma Study Group

✍ M. Feuring-Buske; M. Kneba; M. Unterhalt; A. Engert; M. Gramatzki; E. Hiller; L. 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 90 KB